Charlie Campbell Joins MicroCare, Will Focus on Medical Infection Prevention

MicroCare, LLC is pleased to announce that Charlie Campbell has joined the company as Key Account Manager. Charlie is responsible for the growth and development of the MicroCare Medical Infection Prevention product line.

Charlie Campbell joins MicroCare with nearly 25 years of experience in sales and business development in the medical supply industry, holding sales management positions with PSS World Medical/Gulf South Medical and most recently, Angelini Pharma. Charlie was directly responsible for creating and growing distribution partnerships as well as nurturing multi-million-dollar territories.

Charlie Campbell holds a Bachelor of Science degree from Florida State University.

“I’m excited to join the MicroCare team,” Charlie said. “Providing infection prevention products that can ultimately positively impact the health of a patient is very rewarding.  MicroCare is an innovative company that is always finding new ways and developing new products to meet patients’ evolving needs.”

Tyler Longenecker, Commercial Sales Manager is pleased that Charlie has joined the company. “With Charlie’s experience and knowledge of the medical markets, he will help us reach more customers quickly, further expand our distributor partner network and strengthen our reputation as the cleaning experts in the medical infection prevention industry.”

 

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.